Irvine, CA, United States of America

Prem Swaroop Mohanty

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Prem Swaroop Mohanty

Introduction: Prem Swaroop Mohanty is a notable inventor based in Irvine, California. His contributions to the field of pharmaceutical innovations have led to the granting of four patents, showcasing his expertise and creativity. Mohanty's work primarily involves the development of advanced formulations that improve the efficacy and delivery of pharmaceutical compounds.

Latest Patents: Among his recent inventions, one significant patent is titled "Solid complex, preparations and uses thereof." This patent describes a solid complex that includes a specific compound along with γ-cyclodextrin. The formulation presents various preparations and uses, highlighting its potential in pharmaceutical applications. Another important patent is for "Suspensions of cyclosporin A form 2," which discusses new methods of formulating a crucial immunosuppressant drug.

Career Highlights: Prem Swaroop Mohanty has made substantial contributions during his tenure at Allergan, Inc., a leading company in the pharmaceutical industry. His innovative ideas and dedication have propelled the development of effective solutions in drug formulation, positioning him as a key figure in his field.

Collaborations: Throughout his career, Mohanty has worked alongside accomplished colleagues, such as Anuradha V Gore and E Quinn Farnes. These collaborations have further enhanced his inventive capabilities, leading to groundbreaking advancements in their respective projects.

Conclusion: Prem Swaroop Mohanty exemplifies the spirit of innovation in the pharmaceutical sector. His patents reflect his commitment to enhancing drug formulations, ultimately improving patient outcomes. As an inventor, his ongoing work promises to open new avenues in pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…